Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong Ivan Horak?

Ivan D. Horak

Chief Scientific and Medical Officer

Symphogen Inc

Direct Phone: (908) ***-****direct phone

Email: i***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Symphogen Inc

50 Division St Suite 503

Somerville, New Jersey,08876

United States

Company Description

Symphogen is a private biopharmaceutical company leading the field of recombinant antibody mixtures for therapeutic use in oncology. The European-based company is developing next-generation antibody therapeutics for the treatment of cancer. Symphogen is dedica... more.

Find other employees at this company (134)

Background Information

Employment History

Chief Scientific Officer and President of Research and Development

Eznon


CSO and Chief Marketing Officer

The Global Leaders


Clinical Research Positions

Janssen L.P


National Cancer Institute


President for Research and Development, Chief Scientific Officer

Enzon Pharmaceuticals , Inc.


Chief Scientific Officer

Immunomedics , Inc.


Affiliations

American Association for Cancer Research Inc

Member


American College of Physicians

Fellow


American Association for Cancer Research Inc

Member, Various Committees


Cancer Research

Member, Editorial Board


International Union

Member, Various Committees


Biotechnology Industry Organization

Member of Advisory Board


Editorial

Board Member


All Conferences

Member of Advisory Board


GDS International Ltd

Delegate


Education

M.D. degree

University of Komenius


Web References(78 Total References)


Scientific Advisory Board - symphogen

www.symphogen.com [cached]

Ivan D Horak


Executive Management - symphogen

www.symphogen.com [cached]

Ivan D. Horak, MD, FACP
Head of Global R&D, Chief Scientific and Medical Officer Prior to joining Symphogen, Dr. Horak served as President of Research and Development and Chief Scientific Officer of Enzon Pharmaceuticals Inc. Before that, Dr. Horak served as Chief Scientific Officer of Immunomedics, responsible for development of novel antibodies. Dr. Horak has authored over 70 peer-reviewed publications and several book chapters within the fields of hematology, oncology, and immunology and has served on the editorial boards of several scientific journals. Dr. Horak is board certified oncologist. He is Fellow of American College of Physicians and member of American Association for Cancer Research, American Society of Hematology, and American Society Clinical Oncology.


Symphogen - Executive Management

www.symphogen.com [cached]

Ivan D. Horak, MD, FACP
Chief Scientific Officer and Medical Officer Prior to joining Symphogen, Dr. Horak served as President of Research and Development and Chief Scientific Officer of Enzon Pharmaceuticals Inc. Before that, Dr. Horak served as Chief Scientific Officer of Immunomedics, responsible for development of novel antibodies. Dr. Horak has authored over 70 peer-reviewed publications and several book chapters within the fields of hematology, oncology, and immunology and has served on the editorial boards of several scientific journals. Dr. Horak is board certified oncologist. He is Fellow of American College of Physicians and member of American Association for Cancer Research, American Society of Hematology, and American Society Clinical Oncology.


Archive - symphogen

www.symphogen.com [cached]

Symphogen, a private biopharmaceutical company developing superior antibody therapeutics (monoclonal, monoclonal mixtures and polyclonal) to treat cancer, infectious and autoimmune diseases, announced today the completion of its senior management team with the addition of a new Chief Scientific/Medical Officer, Ivan D. Horak, M.D.,FACP and a new Chief Business Officer, Gayle M Mills.


Readmore - symphogen

www.symphogen.com [cached]

According to Symphogen Chief Scientific Officer and Medical Officer, Ivan D. Horak, MD, FACP,


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory